author-photo

Jennifer D. Tibodeau

Mayo Clinic

11

Papers

364

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.

2012 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (44)
The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation

2012 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (33)
Annatto constituent cis-bixin has selective antimyeloma effects mediated by oxidative stress and associated with inhibition of thioredoxin and thioredoxin reductase

2010 Antioxidants & Redox Signaling
Show All
- Source
- Cite
- Save
Citations (32)
Abstract 3571: The Thioredoxin Reductase Inhibitor Chaetocin has Potent Antineoplastic Effects in Solid Tumors

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase.

2009 Antioxidants & Redox Signaling
Show All
- Source
- Cite
- Save
Citations (80)
Chaetocin, a promising new anti-myeloma agent with in vitro and in vivo activity linked to oxidative stress

2007 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)